News

The Phase I trial will be followed by a Phase IIa trial for the seasonal trivalent vaccine with the recommended H1N1, H3N2 and B influenza strains, which the

Although GeoVax is currently being tested clinically for HIV prevention, this is the first clinical trial in which the same products are being used for treatment of persons

Kinaxo’s acquisition establishes Evotec‘s as an integrated drug discovery and early development partner for pharma and biotechnology companies. Kinaxo’s novel technologies are expected to help Evotec arrive at

APF530 is indicated for the prevention of chemotherapy-induced nausea and vomiting. AP Pharma is in the process of preparing a resubmission responsive to the deficiencies listed in the

The results showed a record viable cell density of 242 million cells per ml at day 15, and a record titer achievement for a Fc-fusion protein of 11.5g

Circassia said PAP-1, a novel topical therapeutic for psoriasis and atopic dermatitis, is a highly specific immunosuppressant and a selective Kv1.3 inhibitor that has ideal topical delivery characteristics.

According to a company-funded report published in the New England Journal of Medicine, both the drugs more than doubled the time that patients lived without their pancreatic neuroendocrine

The Phase II studies are designed to offer valuable insights to guide the selection of the therapeutic indications for which TC-6987 is best suited for later-stage development. The

The study results showed that two distinct twice-daily formulations of DM-1992 maintained therapeutic blood levels of levodopa over 24 hours, Depomed said. Both the formulations are projected, at